Sanofi ends al­most all state per­son­al in­jury law­suits over Zan­tac with undis­closed set­tle­ment

Sanofi has agreed to set­tle about 4,000 cas­es in the sprawl­ing lit­i­ga­tion over the heart­burn drug Zan­tac and claims that it con­tained a car­cino­gen that caused can­cer.

On Thurs­day, Sanofi said that it had reached an agree­ment “in prin­ci­ple” that would re­solve most of the cas­es still pend­ing against the com­pa­ny in state courts out­side of Delaware, adding that the deal re­quires in­di­vid­ual plain­tiffs to agree and will take time to com­plete. Sanofi is not con­ced­ing to any li­a­bil­i­ty and said it is on­ly set­tling the cas­es “to avoid the ex­pense and on­go­ing dis­trac­tion of the lit­i­ga­tion,” a com­pa­ny rep­re­sen­ta­tive said in an emailed state­ment.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER